Reported covered position: BOD/EXIM BANK
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CHILDREN'S HEALTHCARE OF ATLANTA · Firm: ARENTFOX SCHIFF LLP
Autism research programs and autism intervention programs generally, including Medicaid coverage of detection methodologies Department of Health and Human Services programs regarding autism and sickle cell disease research H.R.7148 (Consolidated Appropriations Act, 2026), regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME), sickle cell disease research, and other programs related to pediatric health care Implementation of H.R. 1 (One Big Beautiful Bill Act), Sections 71115, 71116, regarding Medicaid funding Fiscal Year 2027 funding for Children's Hospital Graduate Medical Education (CHGME) program
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CHILDREN'S HEALTHCARE OF ATLANTA · Firm:
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
CREDIT BUILDERS ALLIANCE via ARENTFOX SCHIFF LLP
2026 · third_quarter · Q3
Regulatory proposal regarding implementation of the Community Reinvestment Act
AMERICAN ASSOCIATION OF TEACHING HEALTH CENTERS via ARENTFOX SCHIFF LLP
2026 · third_quarter · Q3
Source: Senate LDA
| MARYWOOD UNIVERSITY | 36 | 2003–2014 |
| ADMETECH FOUNDATION | 33 | 2003–2015 |
| TENNESSEE TECHNOLOGICAL UNIVERSITY | 32 | 2004–2014 |
| AMERICAN PUBLIC TRANSPORTATION ASSOCIATION | 31 | 2019–2026 |
| FRAGRANCE CREATORS ASSOCIATION | 28 | 2017–2023 |
| MUSIC CHOICE | 26 | 2012–2018 |
| CLARK CONSTRUCTION GROUP, LLC | 23 | 2011–2017 |
| FEDERAL BAR ASSOCIATION | 23 | 2021–2026 |
| HARMAR MOBILITY, LLC | 23 | 2015–2022 |
| MODERN TRANSIT PARTNERSHIP | 22 | 2003–2011 |
| INFECTIOUS DISEASES SOCIETY OF AMERICA | 21 | 2022–2026 |
| OPPORTUNITY FINANCE NETWORK | 20 | 2013–2018 |
| TRUFUND FINANCIAL SERVICES INC | 20 | 2010–2014 |
| LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE, INC | 19 | 2009–2023 |
| PENNSYLVANIA GIVES | 19 | 2013–2017 |
| Exact Sciences Corporation | 17 | 2020–2023 |
| CHURCH & DWIGHT CO., INC. | 16 | 2019–2025 |
| FOUNDATION MEDICINE, INC. | 16 | 2017–2020 |
| ASSOCIATION OF THE GERMAN CONFECTIONERY INDUSTRY | 15 | 2020–2026 |
| CEO COUNCIL FOR GROWTH | 15 | 2013–2016 |
| SOCIETY OF HISPANIC PROFESSIONAL ENGINEERS | 15 | 2021–2024 |
| SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 13 | 2010–2013 |
| TUPPERWARE BRANDS CORPORATION | 13 | 2007–2014 |
| BUSINESS SOFTWARE ALLIANCE | 12 | 2004–2009 |
| CREDIT BUILDERS ALLIANCE | 12 | 2023–2026 |
| EQRX INTERNATIONAL, INC. | 12 | 2019–2022 |
| AMERICAN POLITICAL SCIENCE ASSOCIATION | 11 | 2019–2021 |
| SAB BIOTHERAPEUTICS, INC. | 11 | 2014–2021 |
| STRATO, INC. | 11 | 2018–2021 |
| ATLANTIC AUTOMOTIVE CORP. | 10 | 2014–2016 |
| FMI ACQUISITION, LLC | 10 | 2013–2015 |
| TRAILS ACT LANDOWNERS/PLAINTIFFS (SEPARATE LITIGANTS IN SIMILAR LITIGATION) | 10 | 2011–2013 |
| voestalpine AG | 10 | 2017–2019 |
| JJF MANAGEMENT SERVICES, INC. | 9 | 2009–2010 |
| SILVER DINER, INC. | 9 | 2020–2026 |
| WORK COLLEGES CONSORTIUM | 9 | 2011–2014 |
| Katena Products, Inc. | 8 | 2015–2016 |
| VANTAGESCORE SOLUTIONS, LLC | 8 | 2021–2023 |
| DASTON CORPORATION | 7 | 2003–2005 |
| HEMATECH INC | 7 | 2007–2009 |
| ALLERGAN PLC | 6 | 2010–2014 |
| AMERICAN PHARMACY COOPERATIVE, INC. | 6 | 2021–2023 |
| CAEAR COALITION | 6 | 2004–2012 |
| COMPUTER & COMMUNICATIONS INDUSTRY ASSOCIATION | 6 | 2021–2022 |
| MASSACHUSETTS AMBULANCE ASSOCIATION, INCORPORATED | 6 | 2024–2025 |
| MOSES TAYLOR HOSPITAL | 6 | 2005–2009 |
| NS Brands, Ltd. | 6 | 2019–2021 |
| SANBIO, INC. | 6 | 2017–2019 |
| SOUTHWEST WINDPOWER | 6 | 2007–2009 |
| THE ALICART GROUP, LLC | 6 | 2021–2022 |
| XCEL ENERGY | 6 | 2012–2013 |
| AHVA PROPERTIES, LLC | 5 | 2009–2010 |
| AMERICAN PSYCHOLOGICAL ASSOCIATION PRACTICE ORGANIZATION | 5 | 2018 |
| CSL BEHRING | 5 | 2011–2015 |
| NATIONAL FOUNDATION FOR CREDIT COUNSELING, INC. | 5 | 2009–2010 |
| NAVY MUTUAL AID ASSOCIATION | 5 | 2022–2023 |
| PUERTO RICO FEDERAL AFFAIRS ADMINISTRATION | 5 | 2007–2008 |
| RAYTHEON | 5 | 2008–2009 |
| THE COMMITTEE TO RESTORE DEALER RIGHTS, LLC | 5 | 2009–2010 |
| THE RLJ COMPANIES, LLC | 5 | 2021–2022 |
| VISTRA CORP. | 5 | 2025–2026 |
| BERGSTROM INC. | 4 | 2024–2025 |
| CENTER FOR VEIN RESTORATION | 4 | 2017 |
| EAGLE QUEST INTERNATIONAL, LTD. | 4 | 2019 |
| GENETICS & IVF INSTITUTE, INC. | 4 | 2010–2011 |
| IQOR US INC. | 4 | 2015–2016 |
| KETTERING COLLEGE OF MEDICAL ARTS | 4 | 2003–2004 |
| MARS, INCORPORATED | 4 | 2021–2022 |
| MENTAL HEALTH ASSOCIATION OF NEW YORK CITY, INC. (DBA VIBRANT EMOTIONAL HEALTH) | 4 | 2024–2025 |
| MERCY COLLEGE | 4 | 2010 |
| MOTOR AND EQUIPMENT MANUFACTURERS ASSOCIATION | 4 | 2012–2014 |
| NATIONAL PARKING ASSOCIATION | 4 | 2020 |
| ONE CONCERN, INC. | 4 | 2017–2018 |
| ORGIL INTERNATIONAL GREENHOUSES CORP | 4 | 2004–2005 |
| SC JOHNSON & SON INC | 4 | 2015–2016 |
| T-3 ENERGY SERVICES, INC. | 4 | 2010 |
| UNIV OF OKLAHOMA TULSA | 4 | 2003–2004 |
| WOODROW WILSON PRESIDENTIAL LIBRARY FOUNDATION | 4 | 2006–2007 |
| YORK COUNTY PENNSYLVANIA | 4 | 2005–2006 |
| AMERICAN ASSOCIATION FOR WOUND CARE MANAGEMENT | 3 | 2011 |
| AMERICAN STEAMSHIP OWNERS MUTUAL PROTECTION AND INDEMNITY ASSOCIATION, INC. | 3 | 2020 |
| B/E AEROSPACE, INC. | 3 | 2011 |
| CALLAREMI PONTIAC BUICK CADILLAC GMC, INC. | 3 | 2009 |
| CLEAN FUELS ALLIANCE AMERICA | 3 | 2016–2019 |
| CONANT AUTOMOTIVE RESOURCES, LLC | 3 | 2017 |
| CP KELCO | 3 | 2020 |
| ERIE REGIONAL CHAMBER AND GROWTH PARTNERSHIP | 3 | 2021–2023 |
| EVOLVE MOTORCYCLES LLC | 3 | 2011 |
| FEDBID INC | 3 | 2006 |
| FRED BEANS HOLDINGS, INC. | 3 | 2009 |
| HURON CONSULTING SERVICES LLC | 3 | 2026 |
| MEMORIAL HOSPITAL | 3 | 2006 |
| MERCEDES HOMES, INC. | 3 | 2008 |
| MIDEA AMERICA CORP. | 3 | 2025 |
Autism research programs and autism intervention programs generally, including Medicaid coverage of detection methodologies Department of Health and Human Services programs regarding autism and sickle cell disease research Implementation of H.R. 1 (One Big Beautiful Bill Act), Sections 71115, 71116, regarding Medicaid funding H.R. 9260 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027) Title II, regarding Children's Hospital Graduate Medical Education (CHGME) program, National Institutes of Health funding, sickle cell disease research, and other programs related to pediatric healthcare
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CHILDREN'S HEALTHCARE OF ATLANTA · Firm: ARENTFOX SCHIFF LLP
Autism research programs and autism intervention programs generally, including Medicaid coverage of detection methodologies Department of Health and Human Services programs regarding autism and sickle cell disease research Implementation of H.R. 1 (One Big Beautiful Bill Act), Sections 71115, 71116, regarding Medicaid funding H.R. 9260 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027) Title II, regarding Children's Hospital Graduate Medical Education (CHGME) program, National Institutes of Health funding, sickle cell disease research, and other programs related to pediatric healthcare
Support for prompt action on filling judicial vacancies and on judicial nominations Support for improved security for federal courthouses and federal judges and judiciary personnel Issues pertaining generally to the federal legal system H.R. 1702 (JUDGES Act of 2025), all provisions H.R. 1929 (JUDGES Act of 2025), all provisions Utilization of U.S. Marshals for judicial security Authority for management of federal courthouses and ownership of courthouses
Support for prompt action on filling judicial vacancies and on judicial nominations Support for improved security for federal courthouses and federal judges and judiciary personnel Issues pertaining generally to the federal legal system, including creation of new judgeships H.R. 1702 (JUDGES Act of 2025), all provisions H.R. 1929 (JUDGES Act of 2025), all provisions Utilization of U.S. Marshals for judicial security S. 5194 (Judicial Space and Facilities Management Effectiveness Act of 2026), all provisions
Support for prompt action on filling judicial vacancies and on judicial nominations Support for improved security for federal courthouses and federal judges and judiciary personnel Issues pertaining generally to the federal legal system H.R. 1702 (JUDGES Act of 2025), all provisions H.R. 1929 (JUDGES Act of 2025), all provisions S. 1884 (Holocaust Expropriated Art Recovery Act of 2025), entire bill Utilization of U.S. Marshals for judicial security Authority for management of federal courthouses and ownership of courthouses
Support for prompt action on filling judicial vacancies and on judicial nominations Support for improved security for federal courthouses and federal judges and judiciary personnel Issues pertaining generally to the federal legal system, including creation of new judgeships H.R. 1702 (JUDGES Act of 2025), all provisions H.R. 1929 (JUDGES Act of 2025), all provisions Utilization of U.S. Marshals for judicial security S. 5194 (Judicial Space and Facilities Management Effectiveness Act of 2026), all provisions
Support for prompt action on filling judicial vacancies and on judicial nominations Support for improved security for federal courthouses and federal judges and judiciary personnel Issues pertaining generally to the federal legal system H.R. 1702 (JUDGES Act of 2025), all provisions H.R. 1929 (JUDGES Act of 2025), all provisions Utilization of U.S. Marshals for judicial security Authority for management of federal courthouses and ownership of courthouses
Support for prompt action on filling judicial vacancies and on judicial nominations Support for improved security for federal courthouses and federal judges and judiciary personnel Issues pertaining generally to the federal legal system H.R. 1702 (JUDGES Act of 2025), all provisions H.R. 1929 (JUDGES Act of 2025), all provisions S. 1884 (Holocaust Expropriated Art Recovery Act of 2025), entire bill Utilization of U.S. Marshals for judicial security Authority for management of federal courthouses and ownership of courthouses
Children’s Hospital GME Support Reauthorization Act of 2025
Client: CHILDREN'S HEALTHCARE OF ATLANTA · Firm: ARENTFOX SCHIFF LLP
Section 340B Drug Pricing Program, including H.R. 9599 (SECURE 340B Act), all provisions S. 5244 (SUSTAIN 340B Act), all provisions Sickle cell disease research funding generally Drug pricing reforms generally Mental and behavioral health legislation generally H.R. 2107 (Children's Hospital GME Support Reauthorization Act of 2025), all provisions Site neutral payments to providers generally Federal telehealth policy generally
Children’s Hospital GME Support Reauthorization Act of 2025
Client: CHILDREN'S HEALTHCARE OF ATLANTA · Firm: ARENTFOX SCHIFF LLP
Section 340B Drug Pricing Program Sickle cell disease research funding generally Drug pricing reforms generally Mental and behavioral health legislation generally H.R. 2107 (Children's Hospital GME Support Reauthorization Act of 2025), all provisions Site neutral payments to providers generally Federal telehealth policy generally
Children’s Hospital GME Support Reauthorization Act of 2025
Client: CHILDREN'S HEALTHCARE OF ATLANTA · Firm: ARENTFOX SCHIFF LLP
Section 340B Drug Pricing Program Sickle cell disease research funding generally Drug pricing reforms generally Mental and behavioral health legislation generally H.R. 2107 (Children's Hospital GME Support Reauthorization Act of 2025), all provisions Site neutral payments to providers generally Federal telehealth policy generally
Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025
Client: INFECTIOUS DISEASES SOCIETY OF AMERICA · Firm: ARENTFOX SCHIFF LLP
H.R. 9260 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027), Title II, regarding funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H.R. 4445 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025), entire bill S.4283 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2026)
Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025
Client: INFECTIOUS DISEASES SOCIETY OF AMERICA · Firm: ARENTFOX SCHIFF LLP
H.R. 9260 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027), Title II, regarding funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H.R. 4445 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025), entire bill S.4283 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2026) H.R. 6500 (Continuing Appropriations and Extensions Act, 2027), regarding funding for infectious diseases programs
Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025
Client: INFECTIOUS DISEASES SOCIETY OF AMERICA · Firm: ARENTFOX SCHIFF LLP
H.R. 5304 and S. 2587 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026), Title II, regarding funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H.R. 4445 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025), entire bill H.R.7148 (Consolidated Appropriations Act, 2026), Division B, Title II, regarding funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally Fiscal Year 2027 funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2026
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R. 4552 and S. 2465 (Transportation, Housing and Urban Development, and Related AgenciesAppropriationsAct, 2026), regarding Federal Transit Administration funding Policies related to Mass Transit Account generally H.R.7148 (Consolidated Appropriations Act, 2026), Division D, Title I, regarding Federal Transit Administration funding
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2026
Client: CREDIT BUILDERS ALLIANCE · Firm: ARENTFOX SCHIFF LLP
Federal policies related to rent reporting by tenants of affordable and public housing H.R. 4552 and S. 2465 (Transportation, Housing and Urban Development, and Related AgenciesAppropriationsAct, 2026), Title II, regarding funding for rent reporting H.R.7148 (Consolidated Appropriations Act, 2026), Division D, Title II, regarding funding for rent reporting
Safe Transit Accountability Act
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Issues related to advancement of public transportation and infrastructure, including implementation of transportation grant programs Reauthorization of Infrastructure Investment and Jobs Act, regarding federal transit program funding issues related to passenger rail policy, including liability insurance, Private Activity Bonds, and transit project approval processes H.R. 4900 and S. 2945 (Safe Transit Accountability Act), entire bill H.R. 8870 (BUILD America 250 Act), entire bill S. 5203 (TURBO Act), all provisions
Safe Transit Accountability Act
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Issues related to advancement of public transportation and infrastructure, including implementation of transportation grant programs Reauthorization of Infrastructure Investment and Jobs Act, regarding federal transit program funding issues related to passenger rail policy, including liability insurance, Private Activity Bonds, and transit project approval processes H.R. 4900 and S. 2945 (Safe Transit Accountability Act), entire bill H.R. 8870 (BUILD America 250 Act), entire bill
Safe Transit Accountability Act
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Issues related to advancement of public transportation and infrastructure, including implementation of transportation grant programs Reauthorization of Infrastructure Investment and Jobs Act, regarding federal transit program funding issues related to passenger rail policy, including liability insurance, Private Activity Bonds, and transit project approval processes H.R. 4900 and S. 2945 (Safe Transit Accountability Act), entire bill
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: INFECTIOUS DISEASES SOCIETY OF AMERICA · Firm: ARENTFOX SCHIFF LLP
H.R. 5304 and S. 2587 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026), Title II, regarding funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H.R. 4445 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025), entire bill H.R.7148 (Consolidated Appropriations Act, 2026), Division B, Title II, regarding funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally Fiscal Year 2027 funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally
Skin Substitute Access and Payment Reform Act
Client: ORGANOGENESIS INC. · Firm: ARENTFOX SCHIFF LLP
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R.6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill
Skin Substitute Access and Payment Reform Act
Client: ORGANOGENESIS INC. · Firm: ARENTFOX SCHIFF LLP
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations and Discarded Products policy Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026 and CY2027) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026 and CY2027) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R.6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill
Continuing Appropriations and Extensions Act, 2027
Client: INFECTIOUS DISEASES SOCIETY OF AMERICA · Firm: ARENTFOX SCHIFF LLP
H.R. 9260 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027), Title II, regarding funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H.R. 4445 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025), entire bill S.4283 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2026) H.R. 6500 (Continuing Appropriations and Extensions Act, 2027), regarding funding for infectious diseases programs
Continuing Appropriations and Extensions Act, 2027
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R. 9170 (Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2027), regarding Federal Transit Administration funding Policies related to Mass Transit Account generally H.R. 6500 (Continuing Appropriations and Extensions Act, 2027), Divisions A and C, regarding Federal Transit Administration funding
Advanced Wound Care and Regenerative Medicine Access and Reform Act
Client: ORGANOGENESIS INC. · Firm: ARENTFOX SCHIFF LLP
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations and Discarded Products policy Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026 and CY2027) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026 and CY2027) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R.6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill
Advanced Wound Care and Regenerative Medicine Access and Reform Act
Client: ORGANOGENESIS INC. · Firm: ARENTFOX SCHIFF LLP
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R.6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill
Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026
Client: FEDERAL BAR ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Federal judicial pay levels generally H.R.7148 (Consolidated Appropriations Act, 2026), Division E, Title III, regarding funding for the judiciary H.R.6938 (Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026), regarding implementation of the Daniel Anderl Judicial Security and Privacy Act of 2022 H.R. 5166 and S. 3290 (Financial Services and General Government Appropriations Act, 2026), Title III, regarding funding for the judiciary and defender services
Consolidated Appropriations Act, 2026
Client: CREDIT BUILDERS ALLIANCE · Firm: ARENTFOX SCHIFF LLP
Federal policies related to rent reporting by tenants of affordable and public housing H.R. 4552 and S. 2465 (Transportation, Housing and Urban Development, and Related AgenciesAppropriationsAct, 2026), Title II, regarding funding for rent reporting H.R.7148 (Consolidated Appropriations Act, 2026), Division D, Title II, regarding funding for rent reporting
Consolidated Appropriations Act, 2026
Client: CHILDREN'S HEALTHCARE OF ATLANTA · Firm: ARENTFOX SCHIFF LLP
Autism research programs and autism intervention programs generally, including Medicaid coverage of detection methodologies Department of Health and Human Services programs regarding autism and sickle cell disease research H.R.7148 (Consolidated Appropriations Act, 2026), regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME), sickle cell disease research, and other programs related to pediatric health care Implementation of H.R. 1 (One Big Beautiful Bill Act), Sections 71115, 71116, regarding Medicaid funding Fiscal Year 2027 funding for Children's Hospital Graduate Medical Education (CHGME) program
Consolidated Appropriations Act, 2026
Client: FEDERAL BAR ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Federal judicial pay levels generally H.R.7148 (Consolidated Appropriations Act, 2026), Division E, Title III, regarding funding for the judiciary H.R.6938 (Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026), regarding implementation of the Daniel Anderl Judicial Security and Privacy Act of 2022 H.R. 5166 and S. 3290 (Financial Services and General Government Appropriations Act, 2026), Title III, regarding funding for the judiciary and defender services
Consolidated Appropriations Act, 2026
Client: INFECTIOUS DISEASES SOCIETY OF AMERICA · Firm: ARENTFOX SCHIFF LLP
H.R. 5304 and S. 2587 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026), Title II, regarding funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H.R. 4445 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025), entire bill H.R.7148 (Consolidated Appropriations Act, 2026), Division B, Title II, regarding funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally Fiscal Year 2027 funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally
Consolidated Appropriations Act, 2026
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R. 4552 and S. 2465 (Transportation, Housing and Urban Development, and Related AgenciesAppropriationsAct, 2026), regarding Federal Transit Administration funding Policies related to Mass Transit Account generally H.R.7148 (Consolidated Appropriations Act, 2026), Division D, Title I, regarding Federal Transit Administration funding
Consolidated Appropriations Act, 2026
Client: AMERICAN ASSOCIATION OF TEACHING HEALTH CENTERS · Firm: ARENTFOX SCHIFF LLP
Implementation of the Teaching Health Center Graduate Medical Education (THCGME) program generally H.R.7148 (Consolidated Appropriations Act, 2026), Division J, Title IV, Section 6401, regarding funding for THCGME program
PASTEUR Act of 2026
Client: INFECTIOUS DISEASES SOCIETY OF AMERICA · Firm: ARENTFOX SCHIFF LLP
Legislation related to anti-microbial resistance generally Infectious diseases physician work force issues generally H.R.7352 and S. 4875 (PASTEUR Act of 2026), entire bill
PASTEUR Act of 2026
Client: INFECTIOUS DISEASES SOCIETY OF AMERICA · Firm: ARENTFOX SCHIFF LLP
Legislation related to anti-microbial resistance generally Infectious diseases physician work force issues generally H.R.7352 and S. 4875 (PASTEUR Act of 2026), entire bill
PASTEUR Act of 2026
Client: INFECTIOUS DISEASES SOCIETY OF AMERICA · Firm: ARENTFOX SCHIFF LLP
Legislation related to anti-microbial resistance generally Infectious diseases physician work force issues generally H.R.7352 (PASTEUR Act of 2026), entire bill
Real Courts, Rule of Law Act of 2026
Client: FEDERAL BAR ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R.7836 (Real Courts, Rule of Law Act of 2026), generally
Real Courts, Rule of Law Act of 2026
Client: FEDERAL BAR ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R.7836 (Real Courts, Rule of Law Act of 2026), generally
Real Courts, Rule of Law Act of 2026
Client: FEDERAL BAR ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R.7836 and S. 5094 (Real Courts, Rule of Law Act of 2026), generally
Housing, artificial intelligence, and data privacy; H.R.8413 (SECURE Data Act), generally; Implementation of 21st Century ROAD to Housing Act
H.R. 8413 (SECURE Data Act), regarding housing and multiple listing services Implementation of 21st Century ROAD to Housing Act, regarding multiple listing services
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027
Client: FEDERAL BAR ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Federal judicial pay levels generally H.R. 8845 (Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027), Title II, regarding implementation of the Daniel Anderl Judicial Security and Privacy Act of 2022 H.R. 8495 (Financial Services and General Government Appropriations Act, 2027), Title III, regarding funding for the judiciary and defender services Department of Justice implementation of the Daniel Anderl Judicial Security and Privacy Act of 2022
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027
Client: FEDERAL BAR ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Federal judicial pay levels generally H.R. 8845 (Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027), Title II, regarding implementation of the Daniel Anderl Judicial Security and Privacy Act of 2022 H.R. 8495 (Financial Services and General Government Appropriations Act, 2027), Title III, regarding funding for the judiciary and defender services Department of Justice implementation of the Daniel Anderl Judicial Security and Privacy Act of 2022
BUILD America 250 Act
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Issues related to advancement of public transportation and infrastructure, including implementation of transportation grant programs Reauthorization of Infrastructure Investment and Jobs Act, regarding federal transit program funding issues related to passenger rail policy, including liability insurance, Private Activity Bonds, and transit project approval processes H.R. 4900 and S. 2945 (Safe Transit Accountability Act), entire bill H.R. 8870 (BUILD America 250 Act), entire bill S. 5203 (TURBO Act), all provisions
BUILD America 250 Act
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Issues related to advancement of public transportation and infrastructure, including implementation of transportation grant programs Reauthorization of Infrastructure Investment and Jobs Act, regarding federal transit program funding issues related to passenger rail policy, including liability insurance, Private Activity Bonds, and transit project approval processes H.R. 4900 and S. 2945 (Safe Transit Accountability Act), entire bill H.R. 8870 (BUILD America 250 Act), entire bill
Energy and Water Development and Related Agencies Appropriations Act, 2027
Client: VISTRA CORP. · Firm: ARENTFOX SCHIFF LLP
H.R.9022 (Energy and Water Development and Related Agencies Appropriations Act, 2027), regarding funding for Joppa Plant decommissioning project Department of Energy contractual reimbursement obligations for Joppa Plant
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2027
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R. 9170 (Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2027), regarding Federal Transit Administration funding Policies related to Mass Transit Account generally H.R. 6500 (Continuing Appropriations and Extensions Act, 2027), Divisions A and C, regarding Federal Transit Administration funding
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2027
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R. 9170 (Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2027), regarding Federal Transit Administration funding Policies related to Mass Transit Account generally
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: INFECTIOUS DISEASES SOCIETY OF AMERICA · Firm: ARENTFOX SCHIFF LLP
H.R. 9260 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027), Title II, regarding funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H.R. 4445 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025), entire bill S.4283 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2026) H.R. 6500 (Continuing Appropriations and Extensions Act, 2027), regarding funding for infectious diseases programs
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: CHILDREN'S HEALTHCARE OF ATLANTA · Firm: ARENTFOX SCHIFF LLP
Autism research programs and autism intervention programs generally, including Medicaid coverage of detection methodologies Department of Health and Human Services programs regarding autism and sickle cell disease research Implementation of H.R. 1 (One Big Beautiful Bill Act), Sections 71115, 71116, regarding Medicaid funding H.R. 9260 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027) Title II, regarding Children's Hospital Graduate Medical Education (CHGME) program, National Institutes of Health funding, sickle cell disease research, and other programs related to pediatric healthcare
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: INFECTIOUS DISEASES SOCIETY OF AMERICA · Firm: ARENTFOX SCHIFF LLP
H.R. 9260 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027), Title II, regarding funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H.R. 4445 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025), entire bill S.4283 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2026)
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: CHILDREN'S HEALTHCARE OF ATLANTA · Firm: ARENTFOX SCHIFF LLP
Autism research programs and autism intervention programs generally, including Medicaid coverage of detection methodologies Department of Health and Human Services programs regarding autism and sickle cell disease research Implementation of H.R. 1 (One Big Beautiful Bill Act), Sections 71115, 71116, regarding Medicaid funding H.R. 9260 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027) Title II, regarding Children's Hospital Graduate Medical Education (CHGME) program, National Institutes of Health funding, sickle cell disease research, and other programs related to pediatric healthcare
Section 340B Drug Pricing Program, including H.R. 9599 (SECURE 340B Act), all provisions S. 5244 (SUSTAIN 340B Act), all provisions Sickle cell disease research funding generally Drug pricing reforms generally Mental and behavioral health legislation generally H.R. 2107 (Children's Hospital GME Support Reauthorization Act of 2025), all provisions Site neutral payments to providers generally Federal telehealth policy generally
Patients First Act of 2026
Client: INFECTIOUS DISEASES SOCIETY OF AMERICA · Firm: ARENTFOX SCHIFF LLP
Medicare reimbursement regarding evaluation and management services by infectious disease physicians and practice expense policies Calendar Year 2027 Physician Fee Schedule H.R. 9693 (Patients First Act of 2026), entire bill
Holocaust Expropriated Art Recovery Act of 2025
Client: FEDERAL BAR ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Support for prompt action on filling judicial vacancies and on judicial nominations Support for improved security for federal courthouses and federal judges and judiciary personnel Issues pertaining generally to the federal legal system H.R. 1702 (JUDGES Act of 2025), all provisions H.R. 1929 (JUDGES Act of 2025), all provisions S. 1884 (Holocaust Expropriated Art Recovery Act of 2025), entire bill Utilization of U.S. Marshals for judicial security Authority for management of federal courthouses and ownership of courthouses
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2026
Client: CREDIT BUILDERS ALLIANCE · Firm: ARENTFOX SCHIFF LLP
Federal policies related to rent reporting by tenants of affordable and public housing H.R. 4552 and S. 2465 (Transportation, Housing and Urban Development, and Related AgenciesAppropriationsAct, 2026), Title II, regarding funding for rent reporting H.R.7148 (Consolidated Appropriations Act, 2026), Division D, Title II, regarding funding for rent reporting
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2026
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R. 4552 and S. 2465 (Transportation, Housing and Urban Development, and Related AgenciesAppropriationsAct, 2026), regarding Federal Transit Administration funding Policies related to Mass Transit Account generally H.R.7148 (Consolidated Appropriations Act, 2026), Division D, Title I, regarding Federal Transit Administration funding
Skin Substitute Access and Payment Reform Act of 2025
Client: ORGANOGENESIS INC. · Firm: ARENTFOX SCHIFF LLP
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations and Discarded Products policy Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026 and CY2027) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026 and CY2027) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R.6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill
Skin Substitute Access and Payment Reform Act of 2025
Client: ORGANOGENESIS INC. · Firm: ARENTFOX SCHIFF LLP
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R.6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
Client: INFECTIOUS DISEASES SOCIETY OF AMERICA · Firm: ARENTFOX SCHIFF LLP
H.R. 5304 and S. 2587 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026), Title II, regarding funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H.R. 4445 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025), entire bill H.R.7148 (Consolidated Appropriations Act, 2026), Division B, Title II, regarding funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally Fiscal Year 2027 funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally
Safe Transit Accountability Act
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Issues related to advancement of public transportation and infrastructure, including implementation of transportation grant programs Reauthorization of Infrastructure Investment and Jobs Act, regarding federal transit program funding issues related to passenger rail policy, including liability insurance, Private Activity Bonds, and transit project approval processes H.R. 4900 and S. 2945 (Safe Transit Accountability Act), entire bill H.R. 8870 (BUILD America 250 Act), entire bill S. 5203 (TURBO Act), all provisions
Safe Transit Accountability Act
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Issues related to advancement of public transportation and infrastructure, including implementation of transportation grant programs Reauthorization of Infrastructure Investment and Jobs Act, regarding federal transit program funding issues related to passenger rail policy, including liability insurance, Private Activity Bonds, and transit project approval processes H.R. 4900 and S. 2945 (Safe Transit Accountability Act), entire bill H.R. 8870 (BUILD America 250 Act), entire bill
Safe Transit Accountability Act
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Issues related to advancement of public transportation and infrastructure, including implementation of transportation grant programs Reauthorization of Infrastructure Investment and Jobs Act, regarding federal transit program funding issues related to passenger rail policy, including liability insurance, Private Activity Bonds, and transit project approval processes H.R. 4900 and S. 2945 (Safe Transit Accountability Act), entire bill
Ensuring Timely Access to Generics Act of 2025
Client: AMERICAN ASSOCIATION OF TEACHING HEALTH CENTERS · Firm: ARENTFOX SCHIFF LLP
Implementation of the Teaching Health Center Graduate Medical Education (THCGME) program generals Sen. Sanders Amendment No. 3 to S 3014 (Ensuring Timely Access to Generics Act of 2025), regarding increased funding for teaching health centers
Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2026
Client: INFECTIOUS DISEASES SOCIETY OF AMERICA · Firm: ARENTFOX SCHIFF LLP
H.R. 9260 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027), Title II, regarding funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H.R. 4445 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025), entire bill S.4283 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2026)
Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2026
Client: INFECTIOUS DISEASES SOCIETY OF AMERICA · Firm: ARENTFOX SCHIFF LLP
H.R. 9260 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027), Title II, regarding funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H.R. 4445 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025), entire bill S.4283 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2026) H.R. 6500 (Continuing Appropriations and Extensions Act, 2027), regarding funding for infectious diseases programs
PASTEUR Act of 2026
Client: INFECTIOUS DISEASES SOCIETY OF AMERICA · Firm: ARENTFOX SCHIFF LLP
Legislation related to anti-microbial resistance generally Infectious diseases physician work force issues generally H.R.7352 and S. 4875 (PASTEUR Act of 2026), entire bill
PASTEUR Act of 2026
Client: INFECTIOUS DISEASES SOCIETY OF AMERICA · Firm: ARENTFOX SCHIFF LLP
Legislation related to anti-microbial resistance generally Infectious diseases physician work force issues generally H.R.7352 and S. 4875 (PASTEUR Act of 2026), entire bill
Real Courts, Rule of Law Act of 2026
Client: FEDERAL BAR ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R.7836 and S. 5094 (Real Courts, Rule of Law Act of 2026), generally
Judicial Space and Facilities Management Effectiveness Act of 2026
Client: FEDERAL BAR ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Support for prompt action on filling judicial vacancies and on judicial nominations Support for improved security for federal courthouses and federal judges and judiciary personnel Issues pertaining generally to the federal legal system, including creation of new judgeships H.R. 1702 (JUDGES Act of 2025), all provisions H.R. 1929 (JUDGES Act of 2025), all provisions Utilization of U.S. Marshals for judicial security S. 5194 (Judicial Space and Facilities Management Effectiveness Act of 2026), all provisions
Issues related to advancement of public transportation and infrastructure, including implementation of transportation grant programs Reauthorization of Infrastructure Investment and Jobs Act, regarding federal transit program funding issues related to passenger rail policy, including liability insurance, Private Activity Bonds, and transit project approval processes H.R. 4900 and S. 2945 (Safe Transit Accountability Act), entire bill H.R. 8870 (BUILD America 250 Act), entire bill S. 5203 (TURBO Act), all provisions
Section 340B Drug Pricing Program, including H.R. 9599 (SECURE 340B Act), all provisions S. 5244 (SUSTAIN 340B Act), all provisions Sickle cell disease research funding generally Drug pricing reforms generally Mental and behavioral health legislation generally H.R. 2107 (Children's Hospital GME Support Reauthorization Act of 2025), all provisions Site neutral payments to providers generally Federal telehealth policy generally
Transitioning Research to Ensure Appropriate Treatment of Water Act
Client: FEDERAL BAR ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Federal judicial pay levels generally H.R.7148 (Consolidated Appropriations Act, 2026), Division E, Title III, regarding funding for the judiciary H.R.6938 (Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026), regarding implementation of the Daniel Anderl Judicial Security and Privacy Act of 2022 H.R. 5166 and S. 3290 (Financial Services and General Government Appropriations Act, 2026), Title III, regarding funding for the judiciary and defender services
Puerto Rico Nutrition Assistance Fairness Act of 2022
Client: FEDERAL BAR ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Federal judicial pay levels generally H.R. 8845 (Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027), Title II, regarding implementation of the Daniel Anderl Judicial Security and Privacy Act of 2022 H.R. 8495 (Financial Services and General Government Appropriations Act, 2027), Title III, regarding funding for the judiciary and defender services Department of Justice implementation of the Daniel Anderl Judicial Security and Privacy Act of 2022
Puerto Rico Nutrition Assistance Fairness Act of 2022
Client: FEDERAL BAR ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Federal judicial pay levels generally H.R. 8845 (Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027), Title II, regarding implementation of the Daniel Anderl Judicial Security and Privacy Act of 2022 H.R. 8495 (Financial Services and General Government Appropriations Act, 2027), Title III, regarding funding for the judiciary and defender services Department of Justice implementation of the Daniel Anderl Judicial Security and Privacy Act of 2022
National MEP Supply Chain Database Act of 2022
Client: FEDERAL BAR ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Federal judicial pay levels generally H.R.7148 (Consolidated Appropriations Act, 2026), Division E, Title III, regarding funding for the judiciary H.R.6938 (Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026), regarding implementation of the Daniel Anderl Judicial Security and Privacy Act of 2022 H.R. 5166 and S. 3290 (Financial Services and General Government Appropriations Act, 2026), Title III, regarding funding for the judiciary and defender services
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: CHILDREN'S HEALTHCARE OF ATLANTA · Firm: ARENTFOX SCHIFF LLP
Autism research programs and autism intervention programs generally, including Medicaid coverage of detection methodologies Department of Health and Human Services programs regarding autism and sickle cell disease research H. Con. Res. 14, regarding Medicaid funding S. Con. Res. 7 regarding Medicaid funding Fiscal Year 2025 and 2026 Department of Health and Human Services funding regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, sickle cell disease research, and other programs related to pediatric health care H.R. 1 (One Big Beautiful Bill Act), Sections 71115, 71116, regarding Medicaid funding
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Fiscal Year 2026 funding for Federal Transit Administration programs H. Con. Res. 14, regarding Federal Transit Administration funding S. Con. Res. 7, regarding Federal Transit Administration funding H.R. 1 (One Big Beautiful Bill Act), regarding electric vehicles Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: CHILDREN'S HEALTHCARE OF ATLANTA · Firm: ARENTFOX SCHIFF LLP
Autism research programs and autism intervention programs generally, including Medicaid coverage of detection methodologies Department of Health and Human Services programs regarding autism and sickle cell disease research H.R. 1968 (Full-Year Continuing Appropriations and Extensions Act, 2025) regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, sickle cell disease research, and other programs related to pediatric health care H. Con. Res. 14, regarding Medicaid funding S. Con. Res. 7 regarding Medicaid funding Fiscal Year 2025 and 2026 Department of Health and Human Services funding regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, sickle cell disease research, and other programs related to pediatric health care
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: INFECTIOUS DISEASES SOCIETY OF AMERICA · Firm: ARENTFOX SCHIFF LLP
Fiscal Year 2026 funding for Bio-Preparedness Workforce Pilot Program, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H. Con. Res 14, regarding funding for infectious diseases programs generally S. Con. Res 7, regarding funding for infectious diseases programs generally H.R. 1968 (Full-Year Continuing Appropriations and Extensions Act, 2025), regarding funding for Infectious diseases programs FY 2025 funding for infectious diseases programs generally Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: INFECTIOUS DISEASES SOCIETY OF AMERICA · Firm: ARENTFOX SCHIFF LLP
Fiscal Year 2026 funding for Bio-Preparedness Workforce Pilot Program, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H. Con. Res 14, regarding funding for infectious diseases programs generally S. Con. Res 7, regarding funding for infectious diseases programs generally Reauthorization of Bio-Preparedness Workforce Pilot Program H.R. 1 (One Big Beautiful Bill Act), regarding funding for infectious diseases programs generally
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R. 1968 (Full-Year Continuing Appropriations and Extensions Act, 2025), regarding Federal Transit Administration funding Fiscal Year 2026 funding for Federal Transit Administration programs H. Con. Res. 14, regarding Federal Transit Administration funding S. Con. Res. 7, regarding Federal Transit Administration funding
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CHILDREN'S HEALTHCARE OF ATLANTA · Firm: ARENTFOX SCHIFF LLP
Autism research programs and autism intervention programs generally, including Medicaid coverage of detection methodologies Department of Health and Human Services programs regarding autism and sickle cell disease research H.R. 5304 and S. 2587 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026), Title II, regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, sickle cell disease research, and other programs related to pediatric health care Implementation of H.R. 1 (One Big Beautiful Bill Act), Sections 71115, 71116, regarding Medicaid funding H.R. 5371 (Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026), regarding Department of Health and Human Services funding
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE CHILDREN'S HOSPITAL OF PHILADELPHIA · Firm: ARENTFOX SCHIFF LLP
Supplemental Nutrition Assistance Program generally Medicaid program reforms, including telemedicine and prior authorization issues Section 340B Drug Pricing program Drug pricing reforms generally Juvenile mental and behavioral health legislation generally "Food as medicine" nutrition programs generally H.R. 2107 (Children's Hospital GME Support Reauthorization Act of 2025), all provisions Medicare "site neutral" payment policy generally Pediatric cancer research generally Pediatric access to cell and gene therapies generally National Institutes of Health program reforms generally H.R. 1 (One Big Beautiful Bill Act), Section 71115, regarding Medicaid provider taxes H.R. 1509 and S. 752 (Accelerating Kids Access to Care Act of 2025), all provisions Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
Fiscal Year 2026 funding for Federal Transit Administration programs H. Con. Res. 14, regarding Federal Transit Administration funding S. Con. Res. 7, regarding Federal Transit Administration funding H.R. 1 (One Big Beautiful Bill Act), regarding electric vehicles Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CHILDREN'S HEALTHCARE OF ATLANTA · Firm: ARENTFOX SCHIFF LLP
Autism research programs and autism intervention programs generally, including Medicaid coverage of detection methodologies Department of Health and Human Services programs regarding autism and sickle cell disease research H. Con. Res. 14, regarding Medicaid funding S. Con. Res. 7 regarding Medicaid funding Fiscal Year 2025 and 2026 Department of Health and Human Services funding regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, sickle cell disease research, and other programs related to pediatric health care H.R. 1 (One Big Beautiful Bill Act), Sections 71115, 71116, regarding Medicaid funding
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: THE CHILDREN'S HOSPITAL OF PHILADELPHIA · Firm: ARENTFOX SCHIFF LLP
H.R. 1 (One Big Beautiful Bill Act), Title VII, Subtitle B, Chapter 1, regarding Medicaid program reforms Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client, until after her ban expired on August 12, 2025.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CHILDREN'S HEALTHCARE OF ATLANTA · Firm: ARENTFOX SCHIFF LLP
Autism research programs and autism intervention programs generally, including Medicaid coverage of detection methodologies Department of Health and Human Services programs regarding autism and sickle cell disease research Fiscal Year 2025 Department of Health and Human Services funding regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, sickle cell disease research, and other programs related to pediatric health care H.R. 5304 and S. 2587 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026), Title II, regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, sickle cell disease research, and other programs related to pediatric health care H.R. 1 (One Big Beautiful Bill Act), Sections 71115, 71116, regarding Medicaid funding
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN PUBLIC TRANSPORTATION ASSOCIATION · Firm: ARENTFOX SCHIFF LLP
H.R. 1 (One Big Beautiful Bill Act), regarding electric vehicles H.R. 4552 and S. 2465 (Transportation, Housing and Urban Development, and Related AgenciesAppropriationsAct, 2026), regarding Federal Transit Administration funding H. R. 5371 (Continuing Appropriations and Extensions Act, 2026), entire bill Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client, until after her ban expired on August 12, 2025.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: INFECTIOUS DISEASES SOCIETY OF AMERICA · Firm: ARENTFOX SCHIFF LLP
Fiscal Year 2026 funding for Bio-Preparedness Workforce Pilot Program, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H. Con. Res 14, regarding funding for infectious diseases programs generally S. Con. Res 7, regarding funding for infectious diseases programs generally Reauthorization of Bio-Preparedness Workforce Pilot Program H.R. 1 (One Big Beautiful Bill Act), regarding funding for infectious diseases programs generally
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: INFECTIOUS DISEASES SOCIETY OF AMERICA · Firm: ARENTFOX SCHIFF LLP
H.R. 1 (One Big Beautiful Bill Act), regarding funding for infectious diseases programs generally H.R. 5304 and S. 2587 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026), Title II, regarding funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H.R. 5371 (Continuing Appropriations and Extensions Act, 2026), entire bill H.R. 4445 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025), entire bill
Accelerating Kids’ Access to Care Act of 2025
Client: THE CHILDREN'S HOSPITAL OF PHILADELPHIA · Firm: ARENTFOX SCHIFF LLP
Supplemental Nutrition Assistance Program generally Medicaid program reforms, including telemedicine and prior authorization issues Section 340B Drug Pricing program Drug pricing reforms generally Juvenile mental and behavioral health legislation generally "Food as medicine" nutrition programs generally H.R. 2107 (Children's Hospital GME Support Reauthorization Act of 2025), all provisions Medicare "site neutral" payment policy generally Pediatric cancer research generally Pediatric access to cell and gene therapies generally National Institutes of Health program reforms generally H.R. 1 (One Big Beautiful Bill Act), Section 71115, regarding Medicaid provider taxes H.R. 1509 and S. 752 (Accelerating Kids Access to Care Act of 2025), all provisions Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Support for prompt action on filling judicial vacancies and on judicial nominations Support for improved security for federal courthouses and federal judges and judiciary personnel Issues pertaining generally to the federal legal system S. 616 (Foundation of the Federal Bar Association Charter Amendments Act of 2025), all provisions H.R. 1702 (JUDGES Act of 2025), all provisions H.R. 1929 (JUDGES Act of 2025), all provisions
Support for prompt action on filling judicial vacancies and on judicial nominations Support for improved security for federal courthouses and federal judges and judiciary personnel Issues pertaining generally to the federal legal system S. 616 (Foundation of the Federal Bar Association Charter Amendments Act of 2025), all provisions H.R. 1702 (JUDGES Act of 2025), all provisions H.R. 1929 (JUDGES Act of 2025), all provisions S. 1884 (Holocaust Expropriated Art Recovery Act of 2025), entire bill
Support for prompt action on filling judicial vacancies and on judicial nominations Support for improved security for federal courthouses and federal judges and judiciary personnel Issues pertaining generally to the federal legal system S. 616 (Foundation of the Federal Bar Association Charter Amendments Act of 2025), all provisions H.R. 1702 (JUDGES Act of 2025), all provisions H.R. 1929 (JUDGES Act of 2025), all provisions
Support for prompt action on filling judicial vacancies and on judicial nominations Support for improved security for federal courthouses and federal judges and judiciary personnel Issues pertaining generally to the federal legal system S. 616 (Foundation of the Federal Bar Association Charter Amendments Act of 2025), all provisions H.R. 1702 (JUDGES Act of 2025), all provisions H.R. 1929 (JUDGES Act of 2025), all provisions
Support for prompt action on filling judicial vacancies and on judicial nominations Support for improved security for federal courthouses and federal judges and judiciary personnel Issues pertaining generally to the federal legal system S. 616 (Foundation of the Federal Bar Association Charter Amendments Act of 2025), all provisions H.R. 1702 (JUDGES Act of 2025), all provisions H.R. 1929 (JUDGES Act of 2025), all provisions S. 1884 (Holocaust Expropriated Art Recovery Act of 2025), entire bill
Support for prompt action on filling judicial vacancies and on judicial nominations Support for improved security for federal courthouses and federal judges and judiciary personnel Issues pertaining generally to the federal legal system S. 616 (Foundation of the Federal Bar Association Charter Amendments Act of 2025), all provisions H.R. 1702 (JUDGES Act of 2025), all provisions H.R. 1929 (JUDGES Act of 2025), all provisions
Support for prompt action on filling judicial vacancies and on judicial nominations Support for improved security for federal courthouses and federal judges and judiciary personnel Issues pertaining generally to the federal legal system S. 616 (Foundation of the Federal Bar Association Charter Amendments Act of 2025), all provisions H.R. 1702 (JUDGES Act of 2025), all provisions H.R. 1929 (JUDGES Act of 2025), all provisions
Implementation of the Teaching Health Center Graduate Medical Education (THCGME) program generally Funding for Teaching Health Center Graduate Medical Education Program Medicare program cost-reporting for Teaching Health Centers Regulations related to primary care exception in THCGME program
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
HURON CONSULTING SERVICES LLC via ARENTFOX SCHIFF LLP
2026 · third_quarter · Q3
Modernization of technologies and management systems used by Department of Veterans Affairs
Modernization of technologies and management systems used by agencies such as the Department of Veterans Affairs, Department of Health and Human Services, and the Department of Defense
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BANECARE MANAGEMENT LLC via ARENTFOX SCHIFF LLP
2026 · third_quarter · 3T
Department of Health and Human Services processing of filing related to change in ownership and Medicare and Medicaid program eligibility
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
AKIVA HOROWITZ via ARENTFOX SCHIFF LLP
2026 · third_quarter · 3T
Department of Health and Human Services processing of filing related to change in Medicare and Medicaid program eligibility
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
COUNCIL OF MULTIPLE LISTING SERVICES via ARENTFOX SCHIFF LLP
2026 · third_quarter · Q3
Issues involving artificial intelligence, copyright, privacy, and antitrust, regarding multiple listing services
H.R. 8413 (SECURE Data Act), regarding housing and multiple listing services Implementation of 21st Century ROAD to Housing Act, regarding multiple listing services
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORGANOGENESIS INC. via ARENTFOX SCHIFF LLP
2026 · third_quarter · Q3
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations and Discarded Products policy Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026 and CY2027) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026 and CY2027)
Food and Drug Administration policy on chronic wound healing products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FEDERAL BAR ASSOCIATION via ARENTFOX SCHIFF LLP
2026 · third_quarter · Q3
H.R.7836 and S. 5094 (Real Courts, Rule of Law Act of 2026), generally
Support for prompt action on filling judicial vacancies and on judicial nominations Support for improved security for federal courthouses and federal judges and judiciary personnel Issues pertaining generally to the federal legal system, including creation of new judgeships H.R. 1702 (JUDGES Act of 2025), all provisions H.R. 1929 (JUDGES Act of 2025), all provisions Utilization of U.S. Marshals for judicial security S. 5194 (Judicial Space and Facilities Management Effectiveness Act of 2026), all provisions
CHILDREN'S HEALTHCARE OF ATLANTA via ARENTFOX SCHIFF LLP
2026 · third_quarter · Q3
Section 340B Drug Pricing Program, including H.R. 9599 (SECURE 340B Act), all provisions S. 5244 (SUSTAIN 340B Act), all provisions Sickle cell disease research funding generally Drug pricing reforms generally Mental and behavioral health legislation generally H.R. 2107 (Children's Hospital GME Support Reauthorization Act of 2025), all provisions Site neutral payments to providers generally Federal telehealth policy generally
Autism research programs and autism intervention programs generally, including Medicaid coverage of detection methodologies Department of Health and Human Services programs regarding autism and sickle cell disease research Implementation of H.R. 1 (One Big Beautiful Bill Act), Sections 71115, 71116, regarding Medicaid funding H.R. 9260 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027) Title II, regarding Children's Hospital Graduate Medical Education (CHGME) program, National Institutes of Health funding, sickle cell disease research, and other programs related to pediatric healthcare
INFECTIOUS DISEASES SOCIETY OF AMERICA via ARENTFOX SCHIFF LLP
2026 · third_quarter · Q3
Medicare reimbursement regarding evaluation and management services by infectious disease physicians and practice expense policies Calendar Year 2027 Physician Fee Schedule H.R. 9693 (Patients First Act of 2026), entire bill
H.R. 9260 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027), Title II, regarding funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H.R. 4445 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025), entire bill S.4283 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2026) H.R. 6500 (Continuing Appropriations and Extensions Act, 2027), regarding funding for infectious diseases programs
AMERICAN PUBLIC TRANSPORTATION ASSOCIATION via ARENTFOX SCHIFF LLP
2026 · third_quarter · Q3
Issues related to advancement of public transportation and infrastructure, including implementation of transportation grant programs Reauthorization of Infrastructure Investment and Jobs Act, regarding federal transit program funding issues related to passenger rail policy, including liability insurance, Private Activity Bonds, and transit project approval processes H.R. 4900 and S. 2945 (Safe Transit Accountability Act), entire bill H.R. 8870 (BUILD America 250 Act), entire bill S. 5203 (TURBO Act), all provisions
H.R. 9170 (Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2027), regarding Federal Transit Administration funding Policies related to Mass Transit Account generally H.R. 6500 (Continuing Appropriations and Extensions Act, 2027), Divisions A and C, regarding Federal Transit Administration funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BANECARE MANAGEMENT LLC via ARENTFOX SCHIFF LLP
2026 · third_quarter · RR
Department of Health and Human Services processing of filing related to change in ownership and Medicare and Medicaid program eligibility.
AKIVA HOROWITZ via ARENTFOX SCHIFF LLP
2026 · third_quarter · RR
Department of Health and Human Services processing of filing related to change in Medicare and Medicaid program eligibility.
SILVER DINER, INC. via ARENTFOX SCHIFF LLP
2026 · third_quarter · RA
Implementation and possible renewal of restaurant lease at BWI/Thurgood Marshall Airport
COUNCIL OF MULTIPLE LISTING SERVICES via ARENTFOX SCHIFF LLP
2026 · third_quarter · RR
Housing, artificial intelligence, and data privacy; H.R.8413 (SECURE Data Act), generally; Implementation of 21st Century ROAD to Housing Act
ORGANOGENESIS INC. via ARENTFOX SCHIFF LLP
2026 · second_quarter · Q2
Food and Drug Administration policy on chronic wound healing products
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations and Discarded Products policy Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026 and CY2027) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026 and CY2027) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R.6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S HEALTHCARE OF ATLANTA via ARENTFOX SCHIFF LLP
2026 · second_quarter · Q2
Section 340B Drug Pricing Program Sickle cell disease research funding generally Drug pricing reforms generally Mental and behavioral health legislation generally H.R. 2107 (Children's Hospital GME Support Reauthorization Act of 2025), all provisions Site neutral payments to providers generally Federal telehealth policy generally
Autism research programs and autism intervention programs generally, including Medicaid coverage of detection methodologies Department of Health and Human Services programs regarding autism and sickle cell disease research Implementation of H.R. 1 (One Big Beautiful Bill Act), Sections 71115, 71116, regarding Medicaid funding H.R. 9260 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027) Title II, regarding Children's Hospital Graduate Medical Education (CHGME) program, National Institutes of Health funding, sickle cell disease research, and other programs related to pediatric healthcare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VISTRA CORP. via ARENTFOX SCHIFF LLP
2026 · second_quarter · Q2
H.R.9022 (Energy and Water Development and Related Agencies Appropriations Act, 2027), regarding funding for Joppa Plant decommissioning project Department of Energy contractual reimbursement obligations for Joppa Plant
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
INFECTIOUS DISEASES SOCIETY OF AMERICA via ARENTFOX SCHIFF LLP
2026 · second_quarter · Q2
Legislation related to anti-microbial resistance generally Infectious diseases physician work force issues generally H.R.7352 and S. 4875 (PASTEUR Act of 2026), entire bill
Medicare reimbursement regarding evaluation and management services by infectious disease physicians and practice expense policies Calendar Year 2027 Physician Fee Schedule
H.R. 9260 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027), Title II, regarding funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H.R. 4445 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025), entire bill S.4283 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2026)
FEDERAL BAR ASSOCIATION via ARENTFOX SCHIFF LLP
2026 · second_quarter · Q2
Support for prompt action on filling judicial vacancies and on judicial nominations Support for improved security for federal courthouses and federal judges and judiciary personnel Issues pertaining generally to the federal legal system H.R. 1702 (JUDGES Act of 2025), all provisions H.R. 1929 (JUDGES Act of 2025), all provisions Utilization of U.S. Marshals for judicial security Authority for management of federal courthouses and ownership of courthouses
Federal judicial pay levels generally H.R. 8845 (Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027), Title II, regarding implementation of the Daniel Anderl Judicial Security and Privacy Act of 2022 H.R. 8495 (Financial Services and General Government Appropriations Act, 2027), Title III, regarding funding for the judiciary and defender services Department of Justice implementation of the Daniel Anderl Judicial Security and Privacy Act of 2022
ASSOCIATION OF THE GERMAN CONFECTIONERY INDUSTRY via ARENTFOX SCHIFF LLP
2026 · second_quarter · Q2
Imposition of tariffs on German confectionery products
AMERICAN ASSOCIATION OF TEACHING HEALTH CENTERS via ARENTFOX SCHIFF LLP
2026 · second_quarter · Q2
Implementation of the Teaching Health Center Graduate Medical Education (THCGME) program generals Sen. Sanders Amendment No. 3 to S 3014 (Ensuring Timely Access to Generics Act of 2025), regarding increased funding for teaching health centers
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
AMERICAN PUBLIC TRANSPORTATION ASSOCIATION via ARENTFOX SCHIFF LLP
2026 · second_quarter · Q2
Issues related to advancement of public transportation and infrastructure, including implementation of transportation grant programs Reauthorization of Infrastructure Investment and Jobs Act, regarding federal transit program funding issues related to passenger rail policy, including liability insurance, Private Activity Bonds, and transit project approval processes H.R. 4900 and S. 2945 (Safe Transit Accountability Act), entire bill H.R. 8870 (BUILD America 250 Act), entire bill
H.R. 9170 (Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2027), regarding Federal Transit Administration funding Policies related to Mass Transit Account generally
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HURON CONSULTING SERVICES LLC via ARENTFOX SCHIFF LLP
2026 · second_quarter · Q2
Modernization of technologies and management systems used by agencies such as the Department of Veterans Affairs, Department of Health and Human Services, and the Department of Defense
Modernization of technologies and management systems used by agencies such as the Department of Veterans Affairs, Department of Health and Human Services, and the Department of Defense
Modernization of technologies and management systems used by agencies such as the Department of Veterans Affairs, Department of Health and Human Services, and the Department of Defense
HURON CONSULTING SERVICES LLC via ARENTFOX SCHIFF LLP
2026 · second_quarter · RR
Modernization of technologies and management systems used by agencies such as the Department of Veterans Affairs, Department of Health and Human Services, and the Department of Defense
Modernization of technologies and management systems used by agencies such as the Department of Veterans Affairs, Department of Health and Human Services, and the Department of Defense
Modernization of technologies and management systems used by agencies such as the Department of Veterans Affairs, Department of Health and Human Services, and the Department of Defense
ASSOCIATION OF THE GERMAN CONFECTIONERY INDUSTRY via ARENTFOX SCHIFF LLP
2026 · first_quarter · Q1
Imposition of tariffs on German confectionery products
FEDERAL BAR ASSOCIATION via ARENTFOX SCHIFF LLP
2026 · first_quarter · Q1
Support for prompt action on filling judicial vacancies and on judicial nominations Support for improved security for federal courthouses and federal judges and judiciary personnel Issues pertaining generally to the federal legal system H.R. 1702 (JUDGES Act of 2025), all provisions H.R. 1929 (JUDGES Act of 2025), all provisions S. 1884 (Holocaust Expropriated Art Recovery Act of 2025), entire bill Utilization of U.S. Marshals for judicial security Authority for management of federal courthouses and ownership of courthouses
H.R.7836 (Real Courts, Rule of Law Act of 2026), generally
INFECTIOUS DISEASES SOCIETY OF AMERICA via ARENTFOX SCHIFF LLP
2026 · first_quarter · Q1
Legislation related to anti-microbial resistance generally Infectious diseases physician work force issues generally H.R.7352 (PASTEUR Act of 2026), entire bill
H.R. 5304 and S. 2587 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026), Title II, regarding funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H.R. 4445 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025), entire bill H.R.7148 (Consolidated Appropriations Act, 2026), Division B, Title II, regarding funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally Fiscal Year 2027 funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally
CHILDREN'S HEALTHCARE OF ATLANTA via ARENTFOX SCHIFF LLP
2026 · first_quarter · Q1
Section 340B Drug Pricing Program Sickle cell disease research funding generally Drug pricing reforms generally Mental and behavioral health legislation generally H.R. 2107 (Children's Hospital GME Support Reauthorization Act of 2025), all provisions Site neutral payments to providers generally Federal telehealth policy generally
Autism research programs and autism intervention programs generally, including Medicaid coverage of detection methodologies Department of Health and Human Services programs regarding autism and sickle cell disease research H.R.7148 (Consolidated Appropriations Act, 2026), regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME), sickle cell disease research, and other programs related to pediatric health care Implementation of H.R. 1 (One Big Beautiful Bill Act), Sections 71115, 71116, regarding Medicaid funding Fiscal Year 2027 funding for Children's Hospital Graduate Medical Education (CHGME) program
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
ORGANOGENESIS INC. via ARENTFOX SCHIFF LLP
2026 · first_quarter · Q1
Food and Drug Administration policy on chronic wound healing products
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R.6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CREDIT BUILDERS ALLIANCE via ARENTFOX SCHIFF LLP
2026 · first_quarter · Q1
Federal policies related to rent reporting by tenants of affordable and public housing H.R. 4552 and S. 2465 (Transportation, Housing and Urban Development, and Related AgenciesAppropriationsAct, 2026), Title II, regarding funding for rent reporting H.R.7148 (Consolidated Appropriations Act, 2026), Division D, Title II, regarding funding for rent reporting
Filing targets: HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE
AMERICAN PUBLIC TRANSPORTATION ASSOCIATION via ARENTFOX SCHIFF LLP
2026 · first_quarter · Q1
H.R. 4552 and S. 2465 (Transportation, Housing and Urban Development, and Related AgenciesAppropriationsAct, 2026), regarding Federal Transit Administration funding Policies related to Mass Transit Account generally H.R.7148 (Consolidated Appropriations Act, 2026), Division D, Title I, regarding Federal Transit Administration funding
Issues related to advancement of public transportation and infrastructure, including implementation of transportation grant programs Reauthorization of Infrastructure Investment and Jobs Act, regarding federal transit program funding issues related to passenger rail policy, including liability insurance, Private Activity Bonds, and transit project approval processes H.R. 4900 and S. 2945 (Safe Transit Accountability Act), entire bill
Filing targets: Council on Environmental Quality (CEQ), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ASSOCIATION OF TEACHING HEALTH CENTERS via ARENTFOX SCHIFF LLP
2026 · first_quarter · Q1
Implementation of the Teaching Health Center Graduate Medical Education (THCGME) program generally H.R.7148 (Consolidated Appropriations Act, 2026), Division J, Title IV, Section 6401, regarding funding for THCGME program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PINNACLE BIOLOGICS, INC. via ARENTFOX SCHIFF LLP
2025 · fourth_quarter · Q4
Calendar Year 2026 Hospital Outpatient Prospective Payment System proposed rule regarding Medicare coverage for a Pinnacle biologic product
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ORGANOGENESIS INC. via ARENTFOX SCHIFF LLP
2025 · fourth_quarter · Q4
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R. 5304 and S. 2587 (Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, 2026), regarding reimbursement for chronic wound healing products
Food and Drug Administration policy on chronic wound healing products
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
INFECTIOUS DISEASES SOCIETY OF AMERICA via ARENTFOX SCHIFF LLP
2025 · fourth_quarter · Q4
Legislation related to anti-microbial resistance generally H.R. 6561 (PREVENT HPV Cancers Act of 2025), all provisions Infectious diseases physician work force issues generally
H.R. 5304 and S. 2587 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026), Title II, regarding funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H.R. 5371 (Continuing Appropriations and Extensions Act, 2026), entire bill H.R. 4445 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025), entire bill
FEDERAL BAR ASSOCIATION via ARENTFOX SCHIFF LLP
2025 · fourth_quarter · Q4
Federal judicial pay levels generally H.R. 5342 and S. 2354 (Commerce, Justice, Science, and Related AgenciesAppropriationsAct, 2026), Title II, regarding implementation of the Daniel Anderl Judicial Security and Privacy Act of 2022 and funding for the judiciary generally H.R. 5166 and S. 3290 (Financial Services and General Government Appropriations Act, 2026), Title III, regarding funding for the judiciary generally and defender services H. R. 5371 (Continuing Appropriations and Extensions Act, 2026), entire bill
Support for prompt action on filling judicial vacancies and on judicial nominations Support for improved security for federal courthouses and federal judges and judiciary personnel Issues pertaining generally to the federal legal system S. 616 (Foundation of the Federal Bar Association Charter Amendments Act of 2025), all provisions H.R. 1702 (JUDGES Act of 2025), all provisions H.R. 1929 (JUDGES Act of 2025), all provisions S. 1884 (Holocaust Expropriated Art Recovery Act of 2025), entire bill
CREDIT BUILDERS ALLIANCE via ARENTFOX SCHIFF LLP
2025 · fourth_quarter · Q4
Federal policies related to rent reporting by tenants of affordable and public housing H.R. 4552 and S. 2465 (Transportation, Housing and Urban Development, and Related AgenciesAppropriationsAct, 2026), Title II, regarding funding for rent reporting
Filing targets: Housing & Urban Development, Dept of (HUD)
CHILDREN'S HEALTHCARE OF ATLANTA via ARENTFOX SCHIFF LLP
2025 · fourth_quarter · Q4
Section 340B Drug Pricing Program Sickle cell disease research funding generally Drug pricing reforms generally Mental and behavioral health legislation generally H.R. 2107 (Children's Hospital GME Support Reauthorization Act of 2025), all provisions Site neutral payments to providers generally Federal telehealth policy generally Pediatric Student Loan Repayment program Enhanced premium tax credit
Autism research programs and autism intervention programs generally, including Medicaid coverage of detection methodologies Department of Health and Human Services programs regarding autism and sickle cell disease research H.R. 5304 and S. 2587 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026), Title II, regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, sickle cell disease research, and other programs related to pediatric health care Implementation of H.R. 1 (One Big Beautiful Bill Act), Sections 71115, 71116, regarding Medicaid funding H.R. 5371 (Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026), regarding Department of Health and Human Services funding
ASSOCIATION OF THE GERMAN CONFECTIONERY INDUSTRY via ARENTFOX SCHIFF LLP
2025 · fourth_quarter · Q4
Imposition of tariffs on German confectionery products
AMERICAN PUBLIC TRANSPORTATION ASSOCIATION via ARENTFOX SCHIFF LLP
2025 · fourth_quarter · Q4
H.R. 4552 and S. 2465 (Transportation, Housing and Urban Development, and Related AgenciesAppropriationsAct, 2026), regarding Federal Transit Administration funding H. R. 5371 (Continuing Appropriations and Extensions Act, 2026), entire bill Policies related to Mass Transit Account generally
Issues related to advancement of public transportation and infrastructure, including implementation of transportation grant programs Reauthorization of Infrastructure Investment and Jobs Act, regarding federal transit program funding issues related to passenger rail policy, including liability insurance, Private Activity Bonds, and transit project approval processes H.R. 4900 and S. 2945 (Safe Transit Accountability Act), entire bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ASSOCIATION OF TEACHING HEALTH CENTERS via ARENTFOX SCHIFF LLP
2025 · fourth_quarter · Q4
Implementation of the Teaching Health Center Graduate Medical Education (THCGME) program generally Reauthorization of the Teaching Health Center Graduate Medical Education (THCGME) program S. 2954 (Health Care Workforce Expansion Act of 2025), Section 3, regarding funding for THCGME program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURITAN MEDICAL PRODUCTS CO., LLC via ARENTFOX SCHIFF LLP
2025 · third_quarter · Q3
Issues related to the PREP Act, which provides liability immunity for medical countermeasures during public health emergencies
Filing targets: Council of Economic Advisers (CEA), Executive Office of the President (EOP), White House Office
INFECTIOUS DISEASES SOCIETY OF AMERICA via ARENTFOX SCHIFF LLP
2025 · third_quarter · Q3
Legislation related to anti-microbial resistance generally
H.R. 1 (One Big Beautiful Bill Act), regarding funding for infectious diseases programs generally H.R. 5304 and S. 2587 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026), Title II, regarding funding for workforce programs, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H.R. 5371 (Continuing Appropriations and Extensions Act, 2026), entire bill H.R. 4445 (Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025), entire bill
PINNACLE BIOLOGICS, INC. via ARENTFOX SCHIFF LLP
2025 · third_quarter · Q3
Calendar Year 2026 Hospital Outpatient Prospective Payment System proposed rule regarding Medicare coverage for a Pinnacle biologic product
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
VISTRA CORP. via ARENTFOX SCHIFF LLP
2025 · third_quarter · Q3
H.R. 4553 (Energy and Water Development and Related AgenciesAppropriationsAct, 2026), regarding funding for Joppa Plant decommissioning project NOTE: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client, until after her ban expired on August 12, 2025.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES
THE CHILDREN'S HOSPITAL OF PHILADELPHIA via ARENTFOX SCHIFF LLP
2025 · third_quarter · Q3
H.R. 1 (One Big Beautiful Bill Act), Title VII, Subtitle B, Chapter 1, regarding Medicaid program reforms Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client, until after her ban expired on August 12, 2025.
ORGANOGENESIS INC. via ARENTFOX SCHIFF LLP
2025 · third_quarter · Q3
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026) S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill NOTE: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client, until after her ban expired on August 12, 2025.
Food and Drug Administration policy on chronic wound healing products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FEDERAL BAR ASSOCIATION via ARENTFOX SCHIFF LLP
2025 · third_quarter · Q3
Federal judicial pay levels generally H.R. 5342 and S. 2354 (Commerce, Justice, Science, and Related AgenciesAppropriationsAct, 2026), Title II, regarding implementation of the Daniel Anderl Judicial Security and Privacy Act of 2022 and funding for the judiciary generally H.R. 5166 (Financial Services and General Government Appropriations Act, 2026), Title III, regarding funding for the judiciary generally and defender services H. R. 5371 (Continuing Appropriations and Extensions Act, 2026), entire bill
Support for prompt action on filling judicial vacancies and on judicial nominations Support for improved security for federal courthouses and federal judges and judiciary personnel Issues pertaining generally to the federal legal system S. 616 (Foundation of the Federal Bar Association Charter Amendments Act of 2025), all provisions H.R. 1702 (JUDGES Act of 2025), all provisions H.R. 1929 (JUDGES Act of 2025), all provisions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CREDIT BUILDERS ALLIANCE via ARENTFOX SCHIFF LLP
2025 · third_quarter · Q3
Federal policies related to rent reporting by tenants of affordable and public housing Fiscal Year 2025 Department of Housing and Urban Development funding for rent reporting H.R. 4552 and S. 2465 (Transportation, Housing and Urban Development, and Related AgenciesAppropriationsAct, 2026), Title II, regarding funding for rent reporting
Filing targets: HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE
AMERICAN PUBLIC TRANSPORTATION ASSOCIATION via ARENTFOX SCHIFF LLP
2025 · third_quarter · Q3
H.R. 1 (One Big Beautiful Bill Act), regarding electric vehicles H.R. 4552 and S. 2465 (Transportation, Housing and Urban Development, and Related AgenciesAppropriationsAct, 2026), regarding Federal Transit Administration funding H. R. 5371 (Continuing Appropriations and Extensions Act, 2026), entire bill Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client, until after her ban expired on August 12, 2025.
Issues related to advancement of public transportation and infrastructure, including implementation of transportation grant programs Reauthorization of Infrastructure Investment and Jobs Act, regarding federal transit program funding and issues related to passenger rail policy, including liability insurance H.R. 4900 (Safe Transit Accountability Act), entire bill Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client, until after her ban expired on August 12, 2025.
CHILDREN'S HEALTHCARE OF ATLANTA via ARENTFOX SCHIFF LLP
2025 · third_quarter · Q3
Section 340B Drug Pricing Program Sickle cell disease research funding generally Drug pricing reforms generally Mental and behavioral health legislation generally H.R. 2107 (Children's Hospital GME Support Reauthorization Act of 2025), all provisions Site neutral payments to providers generally Federal telehealth policy generally
Autism research programs and autism intervention programs generally, including Medicaid coverage of detection methodologies Department of Health and Human Services programs regarding autism and sickle cell disease research Fiscal Year 2025 Department of Health and Human Services funding regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, sickle cell disease research, and other programs related to pediatric health care H.R. 5304 and S. 2587 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026), Title II, regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, sickle cell disease research, and other programs related to pediatric health care H.R. 1 (One Big Beautiful Bill Act), Sections 71115, 71116, regarding Medicaid funding
AMERICAN ASSOCIATION OF TEACHING HEALTH CENTERS via ARENTFOX SCHIFF LLP
2025 · third_quarter · Q3
Implementation of the Teaching Health Center Graduate Medical Education (THCGME) program generally Reauthorization of the Teaching Health Center Graduate Medical Education (THCGME) program Fiscal Year 2026 Department of Health and Human Services funding for THCGME program S. 2954 (Health Care Workforce Expansion Act of 2025), Section 3, regarding funding for THCGME program H.R. 5371 (Continuing Appropriations and Extensions Act, 2026), Division C, Title I, Section 101, regarding funding for THCGME program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHURCH & DWIGHT CO., INC. via ARENTFOX SCHIFF LLP
2025 · third_quarter · Q3
United States trade policies (including tariffs) related to household, personal care, and animal nutrition products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF THE GERMAN CONFECTIONERY INDUSTRY via ARENTFOX SCHIFF LLP
2025 · third_quarter · Q3
Imposition of tariffs on German confectionery products
Filing targets: HOUSE OF REPRESENTATIVES, U.S. Trade Representative (USTR)
PINNACLE BIOLOGICS, INC. via ARENTFOX SCHIFF LLP
2025 · third_quarter · RR
Calendar Year 2026 Hospital Outpatient Prospective Payment System proposed rule regarding Medicare coverage for a Pinnacle biologic product
PURITAN MEDICAL PRODUCTS CO., LLC via ARENTFOX SCHIFF LLP
2025 · third_quarter · RR
Issues related to the PREP Act, which provides liability immunity for medical countermeasures during public health emergencies
BERGSTROM INC. via ARENTFOX SCHIFF LLP
2025 · second_quarter · Q2
Issues related to implementation of tariffs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MIDEA AMERICA CORP. via ARENTFOX SCHIFF LLP
2025 · second_quarter · Q2
U.S. trade policies, including imposition of tariffs, impacting the importation of household appliances
VISTRA CORP. via ARENTFOX SCHIFF LLP
2025 · second_quarter · Q2
Fiscal Year 2026 Department of Energy funding for Joppa Plant decommissioning project Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
THE CHILDREN'S HOSPITAL OF PHILADELPHIA via ARENTFOX SCHIFF LLP
2025 · second_quarter · Q2
Supplemental Nutrition Assistance Program generally Medicaid program reforms, including telemedicine and prior authorization issues Section 340B Drug Pricing program Drug pricing reforms generally Juvenile mental and behavioral health legislation generally "Food as medicine" nutrition programs generally H.R. 2107 (Children's Hospital GME Support Reauthorization Act of 2025), all provisions Medicare "site neutral" payment policy generally Pediatric cancer research generally Pediatric access to cell and gene therapies generally National Institutes of Health program reforms generally H.R. 1 (One Big Beautiful Bill Act), Section 71115, regarding Medicaid provider taxes H.R. 1509 and S. 752 (Accelerating Kids Access to Care Act of 2025), all provisions Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Funding for cell and gene therapy generally Fiscal Year 2025 and 2026 Department of Health and Human Services funding, regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, Centers for Disease Control, and other programs related to pediatric health care
ORGANOGENESIS INC. via ARENTFOX SCHIFF LLP
2025 · second_quarter · Q2
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products
Food and Drug Administration policy on chronic wound healing products
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
INFECTIOUS DISEASES SOCIETY OF AMERICA via ARENTFOX SCHIFF LLP
2025 · second_quarter · Q2
Legislation related to anti-microbial resistance generally
Fiscal Year 2026 funding for Bio-Preparedness Workforce Pilot Program, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H. Con. Res 14, regarding funding for infectious diseases programs generally S. Con. Res 7, regarding funding for infectious diseases programs generally Reauthorization of Bio-Preparedness Workforce Pilot Program H.R. 1 (One Big Beautiful Bill Act), regarding funding for infectious diseases programs generally
FEDERAL BAR ASSOCIATION via ARENTFOX SCHIFF LLP
2025 · second_quarter · Q2
Federal judicial pay levels generally Fiscal Year 2026 funding regarding implementation of the Daniel Anderl Judicial Security and Privacy Act of 2022 and funding for the judiciary generally
Support for prompt action on filling judicial vacancies and on judicial nominations Support for improved security for federal courthouses and federal judges and judiciary personnel Issues pertaining generally to the federal legal system S. 616 (Foundation of the Federal Bar Association Charter Amendments Act of 2025), all provisions H.R. 1702 (JUDGES Act of 2025), all provisions H.R. 1929 (JUDGES Act of 2025), all provisions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CREDIT BUILDERS ALLIANCE via ARENTFOX SCHIFF LLP
2025 · second_quarter · Q2
Federal policies related to rent reporting by tenants of affordable and public housing Fiscal Year 2025 and 2026 Department of Housing and Urban Development funding for rent reporting
Federal policies regarding consumer education and financial literacy, including Consumer Financial Protection Board policies
Filing targets: HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE
CHURCH & DWIGHT CO., INC. via ARENTFOX SCHIFF LLP
2025 · second_quarter · Q2
United States trade policies (including tariffs) related to household, personal care, and animal nutrition products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S HEALTHCARE OF ATLANTA via ARENTFOX SCHIFF LLP
2025 · second_quarter · Q2
Section 340B Drug Pricing Program Sickle cell disease research funding generally Drug pricing reforms generally Mental and behavioral health legislation generally H.R. 2017 (Children's Hospital GME Support Reauthorization Act of 2025), all provisions Site neutral payments to providers generally
Autism research programs and autism intervention programs generally, including Medicaid coverage of detection methodologies Department of Health and Human Services programs regarding autism and sickle cell disease research H. Con. Res. 14, regarding Medicaid funding S. Con. Res. 7 regarding Medicaid funding Fiscal Year 2025 and 2026 Department of Health and Human Services funding regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, sickle cell disease research, and other programs related to pediatric health care H.R. 1 (One Big Beautiful Bill Act), Sections 71115, 71116, regarding Medicaid funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF THE GERMAN CONFECTIONERY INDUSTRY via ARENTFOX SCHIFF LLP
2025 · second_quarter · Q2
Imposition of tariffs on German confectionery products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
AMERICAN PUBLIC TRANSPORTATION ASSOCIATION via ARENTFOX SCHIFF LLP
2025 · second_quarter · Q2
Fiscal Year 2026 funding for Federal Transit Administration programs H. Con. Res. 14, regarding Federal Transit Administration funding S. Con. Res. 7, regarding Federal Transit Administration funding H.R. 1 (One Big Beautiful Bill Act), regarding electric vehicles Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Issues related to advancement of public transportation and infrastructure, including implementation of transportation grant programs Reauthorization of Infrastructure Investment and Jobs Act, regarding federal transit program funding Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
AMERICAN ASSOCIATION OF TEACHING HEALTH CENTERS via ARENTFOX SCHIFF LLP
2025 · second_quarter · Q2
Implementation of the Teaching Health Center Graduate Medical Education (THCGME) program generally Reauthorization of the Teaching Health Center Graduate Medical Education (THCGME) program Fiscal Year 2026 Department of Health and Human Services funding for THCGME program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MENTAL HEALTH ASSOCIATION OF NEW YORK CITY, INC. (DBA VIBRANT EMOTIONAL HEALTH) via ARENTFOX SCHIFF LLP
2025 · first_quarter · 1A
H.R. 1968 (Full-Year Continuing Appropriations and Extensions Act, 2025), regarding funding for the 988 Suicide & Crisis Lifeline H.R. 912 and S. 1007 (9-8-8 Lifeline Cybersecurity Responsibility Act), regarding funding for the 988 Suicide & Crisis Lifeline Fiscal Year 2025 and 2026 Departments of Labor, Health and Human Services, and Education regarding funding for the 988 Suicide & Crisis Lifeline Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MIDEA AMERICA CORP. via ARENTFOX SCHIFF LLP
2025 · first_quarter · Q1
U.S. trade policies, including imposition of tariffs, impacting the importation of household appliances
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VISTRA CORP. via ARENTFOX SCHIFF LLP
2025 · first_quarter · Q1
Fiscal Year 2025 and 2026 Department of Energy funding for Joppa Plant decommissioning project Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Filing targets: SENATE
CHURCH & DWIGHT CO., INC. via ARENTFOX SCHIFF LLP
2025 · first_quarter · Q1
United States trade policies (including tariffs) related to household, personal care, and animal nutrition products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE CHILDREN'S HOSPITAL OF PHILADELPHIA via ARENTFOX SCHIFF LLP
2025 · first_quarter · Q1
Supplemental Nutrition Assistance Program generally Medicaid program reforms, including telemedicine and prior authorization issues Section 340B Drug Pricing program Drug pricing reforms generally Juvenile mental and behavioral health legislation generally "Food as medicine" nutrition programs generally H.R. 2107 (Children's Hospital GME Support Reauthorization Act of 2025), all provisions Medicare "site neutral" payment policy generally Pediatric cancer research generally Pediatric access to cell and gene therapies generally National Institutes of Health program reforms generally Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
H.R. 1968 (Full-Year Continuing Appropriations and Extensions Act, 2025), regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, Centers for Disease Control, and other programs related to pediatric health care Funding for cell and gene therapy generally Fiscal Year 2025 and 2026 Department of Health and Human Services funding, regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, Centers for Disease Control, and other programs related to pediatric health care
ORGANOGENESIS INC. via ARENTFOX SCHIFF LLP
2025 · first_quarter · Q1
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Food and Drug Administration policy on chronic wound healing products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MENTAL HEALTH ASSOCIATION OF NEW YORK CITY, INC. (DBA VIBRANT EMOTIONAL HEALTH) via ARENTFOX SCHIFF LLP
2025 · first_quarter · Q1
H.R. 1968 (Full-Year Continuing Appropriations and Extensions Act, 2025), regarding funding for the 988 Suicide & Crisis Lifeline H.R. 912 and S. 1007 (9-8-8 Lifeline Cybersecurity Responsibility Act), regarding funding for the 988 Suicide & Crisis Lifeline Fiscal Year 2025 and 2026 Departments of Labor, Health and Human Services, and Education regarding funding for the 988 Suicide & Crisis Lifeline Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MASSACHUSETTS AMBULANCE ASSOCIATION, INCORPORATED via ARENTFOX SCHIFF LLP
2025 · first_quarter · Q1
Centers for Medicare and Medicaid Services (CMS) policy regarding the effect that state health care-related taxes on ambulance services have on the amount of Medicaid payments paid to states
INFECTIOUS DISEASES SOCIETY OF AMERICA via ARENTFOX SCHIFF LLP
2025 · first_quarter · Q1
Legislation related to anti-microbial resistence generally
Fiscal Year 2026 funding for Bio-Preparedness Workforce Pilot Program, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H. Con. Res 14, regarding funding for infectious diseases programs generally S. Con. Res 7, regarding funding for infectious diseases programs generally H.R. 1968 (Full-Year Continuing Appropriations and Extensions Act, 2025), regarding funding for Infectious diseases programs FY 2025 funding for infectious diseases programs generally Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
FEDERAL BAR ASSOCIATION via ARENTFOX SCHIFF LLP
2025 · first_quarter · Q1
H.R. 1968 (Full-Year Continuing Appropriations and Extensions Act, 2025), regarding implementation of the Daniel Anderl Judicial Security and Privacy Act of 2022 and funding for the judiciary generally Federal judicial pay levels generally Fiscal Year 2026 funding regarding implementation of the Daniel Anderl Judicial Security and Privacy Act of 2022 and funding for the judiciary generally
Establishment of an independent federal immigration court
Support for prompt action on filling judicial vacancies and on judicial nominations Support for improved security for federal courthouses and federal judges and judiciary personnel Issues pertaining generally to the federal legal system S. 616 (Foundation of the Federal Bar Association Charter Amendments Act of 2025), all provisions H.R. 1702 (JUDGES Act of 2025), all provisions H.R. 1929 (JUDGES Act of 2025), all provisions
CREDIT BUILDERS ALLIANCE via ARENTFOX SCHIFF LLP
2025 · first_quarter · Q1
Federal policies related to rent reporting by tenants of affordable and public housing Fiscal Year 2025 and 2026 Department of Housing and Urban Development funding for rent reporting H.R. 1968 (Full-Year Continuing Appropriations and Extensions Act, 2025), all provisions
Federal policies regarding consumer education and financial literacy, including Consumer Financial Protection Board policies
Filing targets: HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE
CHILDREN'S HEALTHCARE OF ATLANTA via ARENTFOX SCHIFF LLP
2025 · first_quarter · Q1
Medicaid program reforms, including telemedicine Section 340B Drug Pricing Program Sickle cell disease research funding generally Drug pricing reforms generally Mental and behavioral health legislation generally H.R. 2017 (Children's Hospital GME Support Reauthorization Act of 2025), all provisions Site neutral payments to providers generally Implementation of Autism Collaboration, Accountability, Research, Education, and Support Act of 2024
Autism research programs and autism intervention programs generally, including Medicaid coverage of detection methodologies Department of Health and Human Services programs regarding autism and sickle cell disease research H.R. 1968 (Full-Year Continuing Appropriations and Extensions Act, 2025) regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, sickle cell disease research, and other programs related to pediatric health care H. Con. Res. 14, regarding Medicaid funding S. Con. Res. 7 regarding Medicaid funding Fiscal Year 2025 and 2026 Department of Health and Human Services funding regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, sickle cell disease research, and other programs related to pediatric health care
ASSOCIATION OF THE GERMAN CONFECTIONERY INDUSTRY via ARENTFOX SCHIFF LLP
2025 · first_quarter · Q1
Imposition of tariffs on German confectionery products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN PUBLIC TRANSPORTATION ASSOCIATION via ARENTFOX SCHIFF LLP
2025 · first_quarter · Q1
H.R. 1968 (Full-Year Continuing Appropriations and Extensions Act, 2025), regarding Federal Transit Administration funding Fiscal Year 2026 funding for Federal Transit Administration programs H. Con. Res. 14, regarding Federal Transit Administration funding S. Con. Res. 7, regarding Federal Transit Administration funding
Issues related to advancement of public transportation and infrastructure, including implementation of transportation grant programs Reauthorization of Infrastructure Investment and Jobs Act, regarding federal transit program funding Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ASSOCIATION OF TEACHING HEALTH CENTERS via ARENTFOX SCHIFF LLP
2025 · first_quarter · Q1
Implementation of the Teaching Health Center Graduate Medical Education (THCGME) program generally Reauthorization of the Teaching Health Center Graduate Medical Education (THCGME) program H.R. 1968 (Full-Year Continuing Appropriations and Extensions Act, 2025), regarding funding for THCGME program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHURCH & DWIGHT CO., INC. via ARENTFOX SCHIFF LLP
2025 · first_quarter · RA
United States trade policies (including tariffs) related to household, personal care, and animal nutrition products
MIDEA AMERICA CORP. via ARENTFOX SCHIFF LLP
2025 · first_quarter · RR
US trade policies, including imposition of tariffs, impacting the importation of household appliances
VISTRA CORP. via ARENTFOX SCHIFF LLP
2025 · first_quarter · RR
Department of Energy funding for Joppa Plant decommissioning project
THE CHILDREN'S HOSPITAL OF PHILADELPHIA via ARENTFOX SCHIFF LLP
2024 · fourth_quarter · 4A
Medicaid program reforms, including telemedicine and prior authorization issues Section 340B Drug Pricing program, including H.R. 5378 (Lower Costs, More Transparency Act), Section 202 Drug pricing reforms generally Juvenile mental and behavioral health legislation generally "Food as medicine" nutrition programs generally H.R. 3884 and S. 1852 (Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023), all provisions H.R. 3391 (Gabriella Miller Kids First Research Act 2.0), all provisions H.R. 3887 (Childrens Hospital GME Support Reauthorization Act of 2023), all provisions Medicare "site neutral" payment policy generally, including H.R. 5378 (Lower Costs, More Transparency Act), Section 203 Pediatric cancer research generally Pediatric access to cell and gene therapies generally H.R. 4758 (Accelerating Kids Access to Care Act), all provisions H.R. 7213 (Autism Collaboration, Accountability, Research, Education, and Support Act of 2024), all provisions H.R. 8260 and S. 4350 (Hospital Inpatient Services Modernization Act), all provisions H.R. 10545 (American Relief Act, 2025), regarding HHS program funding and Medicaid program reform provisions National Institutes of Health program reforms generally S. 904 (Sickle Cell Disease Comprehensive Care Act), all provisions Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
INFECTIOUS DISEASES SOCIETY OF AMERICA via ARENTFOX SCHIFF LLP
2024 · fourth_quarter · 4A
H.R. 2940 and S. 1355 (PASTEUR Act of 2023), all provisions H.R. 4420 (Preparedness and Response Reauthorization Act), all provisions H.R. 4421 (Preparing for all Hazards and Pathogens Reauthorization Act), all provisions S. 2333 (Pandemic and All-Hazards Preparedness and Response Act), all provisions Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
H.R. 9029 and S. 4942 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025), Title II, regarding funding for programs dealing with antimicrobial resistance and infectious diseases, including Bio-Preparedness Workforce Pilot Program Fiscal Year 2026 funding for Bio-Preparedness Workforce Pilot Program H.R. 10545 (American Relief Act, 2025), regarding antimicrobial resistance and infectious diseases programs
AMERICAN ASSOCIATION OF TEACHING HEALTH CENTERS via ARENTFOX SCHIFF LLP
2024 · fourth_quarter · 4A
Implementation of the Teaching Health Center Graduate Medical Education (THCGME) program generally Reauthorization of the Teaching Health Center Graduate Medical Education (THCGME) program H.R. 5378 (Lower Costs, More Transparency Act), Section 301, regarding reauthorization of THCGME program S. 2840 (Bipartisan Primary Care and Health Workforce Act), Section 101, regarding reauthorization of THCGME program H.R. 10545 (American Relief Act, 2025), Division C, Title II, Sec. 3201, regarding funding for THCGME program Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE CHILDREN'S HOSPITAL OF PHILADELPHIA via ARENTFOX SCHIFF LLP
2024 · fourth_quarter · Q4
H.R. 9029 and S. 4942 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025), Title II, regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, Advanced Research Projects Agency-Health, and other programs related to pediatric health care Funding for cell and gene therapy generally
Medicaid program reforms, including telemedicine and prior authorization issues Section 340B Drug Pricing program, including H.R. 5378 (Lower Costs, More Transparency Act), Section 202 Drug pricing reforms generally Juvenile mental and behavioral health legislation generally "Food as medicine" nutrition programs generally H.R. 3884 and S. 1852 (Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023), all provisions H.R. 3391 (Gabriella Miller Kids First Research Act 2.0), all provisions H.R. 3887 (Childrens Hospital GME Support Reauthorization Act of 2023), all provisions Medicare "site neutral" payment policy generally, including H.R. 5378 (Lower Costs, More Transparency Act), Section 203 Pediatric cancer research generally Pediatric access to cell and gene therapies generally H.R. 4758 (Accelerating Kids Access to Care Act), all provisions H.R. 7213 (Autism Collaboration, Accountability, Research, Education, and Support Act of 2024), all provisions H.R. 8260 and S. 4350 (Hospital Inpatient Services Modernization Act), all provisions H.R. 10545 (American Relief Act, 2025), regarding HHS program funding and Medicaid program reform provisions National Institutes of Health program reforms generally S. 904 (Sickle Cell Disease Comprehensive Care Act), all provisions
ORGANOGENESIS INC. via ARENTFOX SCHIFF LLP
2024 · fourth_quarter · Q4
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products
Food and Drug Administration policy on chronic wound healing products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVELIS INC. via ARENTFOX SCHIFF LLP
2024 · fourth_quarter · Q4
Issues related to Internal Revenue Code Section 48C investment and Section 45X tax credit
Filing targets: Energy, Dept of, Executive Office of the President (EOP), SENATE
MENTAL HEALTH ASSOCIATION OF NEW YORK CITY, INC. (DBA VIBRANT EMOTIONAL HEALTH) via ARENTFOX SCHIFF LLP
2024 · fourth_quarter · Q4
Policies surrounding and impacting mental health, suicide prevention, and the 988 Suicide & Crisis Lifeline
H.R. 498 and S. 1493 (9-8-8 Lifeline Cybersecurity Responsibility Act), regarding funding for the 988 Suicide & Crisis Lifeline
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
MASSACHUSETTS AMBULANCE ASSOCIATION, INCORPORATED via ARENTFOX SCHIFF LLP
2024 · fourth_quarter · Q4
Centers for Medicare and Medicaid Services (CMS) policy regarding the effect that state health care-related taxes on ambulance services have on the amount of Medicaid payments paid to states
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INFECTIOUS DISEASES SOCIETY OF AMERICA via ARENTFOX SCHIFF LLP
2024 · fourth_quarter · Q4
Medicare reimbursement regarding evaluation and management services by infectious disease physicians, including 2025 Physician Fee Schedule
H.R. 2940 and S. 1355 (PASTEUR Act of 2023), all provisions H.R. 4420 (Preparedness and Response Reauthorization Act), all provisions H.R. 4421 (Preparing for all Hazards and Pathogens Reauthorization Act), all provisions S. 2333 (Pandemic and All-Hazards Preparedness and Response Act), all provisions
H.R. 9029 and S. 4942 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025), Title II, regarding funding for programs dealing with antimicrobial resistance and infectious diseases, including Bio-Preparedness Workforce Pilot Program Fiscal Year 2026 funding for Bio-Preparedness Workforce Pilot Program H.R. 10545 (American Relief Act, 2025), regarding antimicrobial resistance and infectious diseases programs
FEDERAL BAR ASSOCIATION via ARENTFOX SCHIFF LLP
2024 · fourth_quarter · Q4
Support for prompt action on filling judicial vacancies and on judicial nominations Support for improved security for federal courthouses and federal judges and judiciary personnel Issues pertaining generally to the federal legal system S. 2694 (Foundation of the Federal Bar Association Charter Amendments Act of 2023), all provisions S. 2759, H.R. 9625 and S. 4199 (JUDGES Act), all provisions H.R. 7597 (Federal Judgeship Act of 2024), all provisions
H.R. 7724 (Real Courts, Rule of Law Act of 2024), all provisions
H.R. 8773 and S. 4928 (Financial Services and General Government Appropriations Act, 2025), Title III, regarding implementation of the Daniel Anderl Judicial Security and Privacy Act of 2022 and funding for the judiciary generally H.R. 9026 and S. 4795 (Commerce, Justice, Science, and Related Agencies Appropriations Act, 2025), Title II, regarding implementation of the Daniel Anderl Judicial Security and Privacy Act of 2022 Federal judicial pay levels generally
CREDIT BUILDERS ALLIANCE via ARENTFOX SCHIFF LLP
2024 · fourth_quarter · Q4
Federal policies related to rent reporting by tenants of affordable and public housing H.R. 9028 and S. 4796 (Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2025), Title II, regarding rent reporting by tenants of affordable and public housing Fiscal Year 2026 Department of Housing and Urban Development funding for rent reporting
Federal policies regarding consumer education and financial literacy, including Consumer Financial Protection Board policies
Filing targets: HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE
CHILDREN'S HEALTHCARE OF ATLANTA via ARENTFOX SCHIFF LLP
2024 · fourth_quarter · Q4
Medicaid program reforms, including telemedicine Section 340B Drug Pricing Program, including H.R. 5378 (Lower Costs, More Transparency Act), Section 202 Sickle cell disease research funding generally Drug pricing reforms generally Mental and behavioral health legislation generally H.R. 3887 (Childrens Hospital GME Support Reauthorization Act of 2023), all provisions H.R. 3884 and S. 1852 (Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023), all provisions Site neutral payments to providers generally, including H.R. 5378 (Lower Costs, More Transparency Act), Section 203 H.R. 6960 and S. 3765 (Emergency Medical Services for Children (EMSC) Reauthorization Act of 2024), all provisions H.R. 4758 (Accelerating Kids Access to Care Act), all provisions H.R. 7213 (Autism Collaboration, Accountability, Research, Education, and Support Act of 2024), all provisions Federal policies regarding Lab-Developed Tests, generally H.R. 10545 (American Relief Act, 2025), regarding HHS program funding and Medicaid program reform provisions
Federal judicial pay levels generally H.R. 8845 (Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027), Title II, regarding implementation of the Daniel Anderl Judicial Security and Privacy Act of 2022 H.R. 8495 (Financial Services and General Government Appropriations Act, 2027), Title III, regarding funding for the judiciary and defender services Department of Justice implementation of the Daniel Anderl Judicial Security and Privacy Act of 2022
Filing targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Legislation related to anti-microbial resistance generally Infectious diseases physician work force issues generally H.R.7352 and S. 4875 (PASTEUR Act of 2026), entire bill
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
H.R.7836 (Real Courts, Rule of Law Act of 2026), generally
Filing targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
Modernization of technologies and management systems used by agencies such as the Department of Veterans Affairs, Department of Health and Human Services, and the Department of Defense
Modernization of technologies and management systems used by agencies such as the Department of Veterans Affairs, Department of Health and Human Services, and the Department of Defense
Federal judicial pay levels generally H.R.7148 (Consolidated Appropriations Act, 2026), Division E, Title III, regarding funding for the judiciary H.R.6938 (Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026), regarding implementation of the Daniel Anderl Judicial Security and Privacy Act of 2022 H.R. 5166 and S. 3290 (Financial Services and General Government Appropriations Act, 2026), Title III, regarding funding for the judiciary and defender services
Filing targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
Medicare reimbursement regarding evaluation and management services by infectious disease physicians and practice expense policies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Medicare reimbursement regarding evaluation and management services by infectious disease physicians, including 2026 Physician Fee Schedule
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Medicare reimbursement regarding evaluation and management services by infectious disease physicians, including 2026 Physician Fee Schedule
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Medicare reimbursement regarding evaluation and management services by infectious disease physicians, including 2026 Physician Fee Schedule
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Medicare reimbursement regarding evaluation and management services by infectious disease physicians, including 2026 Physician Fee Schedule
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 9029 and S. 4942 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025), Title II, regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, Advanced Research Projects Agency-Health, and other programs related to pediatric health care Funding for cell and gene therapy generally
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Medicare reimbursement regarding evaluation and management services by infectious disease physicians, including 2025 Physician Fee Schedule
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Autism research programs and autism intervention programs generally, including Medicaid coverage of detection methodologies Department of Health and Human Services programs regarding autism and sickle cell disease research H.R. 9029 and S. 4942 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025), Title II, regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, sickle cell disease research, Advanced Research Projects Agency-Health, funding for emergency room modifications, and other programs related to pediatric health care
Filing targets: HOUSE OF REPRESENTATIVES, SENATE